Next Monday and Tuesday will see the team from Labskin attending the 7th Microbiome & Probiotic R&D and Business Forum. Due to Covid-19 travel restrictions this event will be hosted on a virtual platform.
This conference brings together over 300 industry professionals, academics and investment leaders to discuss the most cutting-edge microbiome and probiotic research, challenges and opportunities. The annual event is widely recognized as a key scientific networking event in the microbiome world.
Eric Clarke, Labskin’s Senior Business Development Manager, will present to online attendees on Monday 30th November at 12pm GMT. The title of his presentation is “A Human Skin Equivalent for the investigation of Skin Dysbiosis” and will examine how the Labskin AI platform combined with the use of the Labskin 3D skin model can assist both academic research projects and commercial product development with fast, accurate and cost-saving results. Christofer Kaprelian from Labskin will also attend.
The 2 day event also involves round-table and panel discussions along with a networking system to enable virtual meetings between attendees, academics and business and research representatives. To schedule a meeting please complete the form here to register your interest.
Learn more about the Labskin 3D skin model and the Labskin AI platform. For further information on the event, to register to attend and to view the agenda please visit Microbiome & Probiotics R&D & Business Collaboration Forum: Europe (global-engage.com)